The North America Ureteral Stents Market would witness market growth of 5.8% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 3,479.8 thousand units, showcasing a growth of 5.5% (2019-2022).
These stents are pivotal in urology, offering critical solutions to various medical conditions affecting the urinary system. These tubular, malleable devices are specifically engineered to tackle obstacles associated with urinary flow by offering assistance and promoting the drainage of urine from the kidneys to the bladder. In recent years, the market has expanded due to a number of factors, including the rising incidence of urological disorders, developments in medical technology, and the aging of the population.
Additionally, the adoption of these stents has become widespread in diagnostic and therapeutic contexts. Urologists, nephrologists, and other healthcare professionals routinely deploy these devices to manage various conditions affecting the urinary tract. The stents are commonly employed for diagnostic purposes in suspected or confirmed ureteral obstruction cases. By placing a stent, healthcare professionals can assess the degree and location of the obstruction, helping to guide further diagnostic and treatment decisions. The versatility of these stents has contributed to their widespread adoption, with applications ranging from alleviating urinary obstructions to post-surgical management and treating kidney stones.
North America, including the United States and Canada, has been experiencing a demographic shift towards an older population. This is characterized by a larger proportion of people aged 65 and older compared to younger age groups. Canada's population is growing, and it is also aging. To meet the needs of a growing and aging population, there is a need to construct and renovate healthcare facilities. In 2023, the government of Canada invested over $198 billion to help improve the healthcare system. Therefore, the growing elderly population in North America is expected to boost the demand for these stents in the region.
The US market dominated the North America Ureteral Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $213.2 million by 2030. The Canada market is experiencing a CAGR of 8.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.2% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCS) & Clinics. Based on Material, the market is segmented into Metallic Stents and Polymer Stents (Silicone Stents, Hybrid Stents, and Polyurethane Stents). Based on Product, the market is segmented into Double Pigtail Stent, Open/Closed Pigtail Stent, and Multiloop Stents. Based on Application, the market is segmented into Kidney Stones, Kidney Transplantation, Urinary Incontinence, Tumors, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Ureteral Stents Market is Predict to reach $883.2 Million by 2030, at a CAGR of 6.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Material (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Product (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Application (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Country (Volume, Thousand Units, Revenue, USD Million, 2019-30)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 